HIV/AIDS
Data on HIV/AIDS described by researchers at Washington University, Division of Infectious Diseases
Published in Hepatitis Weekly, August 16th, 2010
Scientists discuss in 'Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220' new findings in HIV/AIDS. "HIV-infected persons are at risk for HBV co-infection which is associated with increased morbidity and mortality. Unfortunately, protective immunity following HBV vaccination in HIV-infected persons is poor," scientists writing in the journal Vaccine report.
"This randomized, phase II, open-label study aimed to evaluate efficacy and safety of 40 mcg HBV vaccine with or without 250 mcg GM-CSF administered at day 0, weeks 4 and 12. HIV-infected...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-08-16)
More Articles from Hepatitis Weekly
- Liver Disease
Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary - Hepatitis C Virus
Data from Centers for Disease Control and Prevention provide new insights into hepatitis C virus - Virology
Data from Federal University of Minas Gerais, Department of Operative Dentistry provide new insights into virology - Interferon Type I
Data from S.J. Costelloe et al provide new insights into interferon type i - Hepatitis
Data on hepatitis detailed by researchers at Sichuan University - Managed Care
Data on managed care described by D. Mitra et al - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
